Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2013
GlobalData's clinical trial report, “Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2013 provides data on the Zollinger-Ellison Syndrome (Gastrinoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Zollinger-Ellison Syndrome (Gastrinoma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Zollinger-Ellison Syndrome (Gastrinoma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Constipation Global Clinical Trials Review, H1, 2013 outlines clinical trials in constipation. The prominent features of this report are-
1. Comprehensive data related to the constipation clinical trials by region, country, and phase, recruitment status. 2. Clinical trials conducted by key companies and institutes / universities / hospitals. The selection of the sponsors is based on their total number of constipation clinical trials conducted by them. 3. A list of key drugs under development or present in the market is provided. The selection of this list is the market size of the products, the number of clinical trials in which they were investigated. 4. The clinical trials compiled in this report are from 70 registries across the globe, taken from 1982 to as of March 2013